Chie Matsuguma
Ube, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Interleukin-33 and Soluble ST2 Levels in Infants with Hypoxic-Ischemic Encephalopathy.
Journal: Neonatology
Published: December 01, 2022
Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease.
Journal: Inflammation
Published: August 08, 2022
Circulating immunocompetent cell profiles during oral cyclosporin therapy for immunoglobulin-resistant Kawasaki disease.
Journal: World journal of pediatrics : WJP
Published: July 19, 2021
Severe persistent pulmonary hypertension in a neonate with Rubinstein-Taybi syndrome accompanied by triple X syndrome.
Journal: Pediatrics and neonatology
Published: January 13, 2021
Utility of Soluble CD163 in the Clinical Management of Patients With Kawasaki Disease.
Journal: Frontiers in pediatrics
Published: September 13, 2019
Dynamics of immunocyte activation during intravenous immunoglobulin treatment in Kawasaki disease.
Journal: Scandinavian journal of rheumatology
Published: July 06, 2019
Circulating endothelial glycocalyx components as a predictive marker of coronary artery lesions in Kawasaki disease.
Journal: International journal of cardiology
Published: January 24, 2019
Refractory primary immune thrombocytopenia in pregnancy requiring splenectomy and repeated intravenous immunoglobulin therapy
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: January 11, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026